Carbazochrome
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Carbazochrome/Adrenochrome Monosemicarbazone is an oxidation product of adrenaline. Carbazochrome is used as a hemostatic in certain hemorrhagic conditions.
Indications
Carbazochrome is primarily indicated in conditions like Bleeding, Epistaxis, Hematuria, Non surgical capillary bleeding, Surgical capillary bleeding.
Contraindications
Carbazochrome is contraindicated in conditions like Hypersensitivity to the drug.
Side Effects
No data regarding the side effects produced by Carbazochrome is available
Warnings
Because of the content of Diprophylline (70mg/ml), the dosage of the 5 mg/ml injection preparation to premature babies, infants and young children should not exceed 0.3 ml. During pregnancy, the benefits of the use of adrenochrome should be weighed against the possible hazards to the fetus.
High Risk Groups
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
0.021 to 0.071 mg/kg (0.046 (0.046)) As recommended. IM — As required.
0.021 to 0.071 mg/kg (0.046 (0.046)) As recommended. SC — As required.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Carbazochrome was found.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
No active brands are currently recorded for this generic.
1 record is present but flagged "Unverified / Legacy" and excluded.